Nectar Lifesciences Limited — Others, 03-07-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Nectar Lifesciences has announced a board meeting to consider the financial results for the quarter and half-year. Its Registrar and Share Transfer Agent, Kfin Technologies, confirmed all shares submitted for dematerialization during the quarter were processed and updated in the register within prescribed timelines. The certificates for accepted securities were cancelled and ownership details were correctly recorded, ensuring seamless trading continuity. This confirms the company’s ongoing compliance with shareholding maintenance and smooth investor transactions.